FdaApplication
NDA 217202
Identifiers
- fda_app_no: NDA217202
Properties
| Property | Value |
|---|---|
| applicant_name | AOP HEALTH US LLC |
| application_type | NDA |
| approval_date | 2024-11-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RAPIBLYK | LANDIOLOL HYDROCHLORIDE | EQ 280MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product